首页 › 基金 › Catalio Capital Management, LP › VNDA

Catalio Capital Management, LP 对 VNDA 的持仓历史

VANDA PHARMACEUTICALS INC · 医疗保健

Catalio Capital Management, LP 在 Q3 2026 的 13F 申报中披露持有 VNDA(VANDA PHARMACEUTICALS INC)11,357 股,市值约 US$226K,约占其申报组合的 0.04%,在其申报持仓中市值排名第 46 位。 Catalio Capital Management, LP 于 Q3 2026 首次申报该持仓。

最新持仓 (Q3 2026)11.36K 股
申报持仓市值$226.46K
组合权重0.04%
首次申报Q3 2026
最近变动新进
更新于2026-11-17

最后更新: 2026-11-17 · 来源: SEC EDGAR Form 13F-HR

Catalio Capital Management, LP 对 VNDA 的持仓演变

Catalio Capital Management, LP 于 Q3 2026 首次披露 VNDA 持仓:11,357 股(约 US$226K)。

逐季持仓明细

季度股数金额变化
Q3 2026 11.36K $226.46K 新进

关于 VNDA 与 13F 数据

VNDA(VANDA PHARMACEUTICALS INC)属于医疗保健行业。我们追踪的基金中还有 50 只申报持有 VNDA,申报仓位最大的包括:ORBIMED ADVISORS LLC (US$482.7M), SR ONE CAPITAL MANAGEMENT, LP (US$198.1M), Bain Capital Life Sciences Investors, LLC (US$134.2M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 VNDA 的基金

查看 VNDA 的全部基金持有人 →

常见问题

How long has Catalio Capital Management, LP held VNDA?

Catalio Capital Management, LP has disclosed VNDA holdings in 1 of the last 1 reported quarters, going back to Q3 2026.

What is Catalio Capital Management, LP's current position in VNDA?

As of Q3 2026, Catalio Capital Management, LP holds 11.36K shares of VNDA (VANDA PHARMACEUTICALS INC), valued at $226.46K, representing 0.04% of its reported portfolio and ranking #46.

Has Catalio Capital Management, LP been buying or selling VNDA?

In the latest 13F filing (Q3 2026), Catalio Capital Management, LP newly opened its position in VNDA.

Which other funds hold VNDA?

Other major institutional holders of VNDA include ORBIMED ADVISORS LLC, SR ONE CAPITAL MANAGEMENT, LP, Bain Capital Life Sciences Investors, LLC, among 50 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.